No apparent effect of cidofovir in epidermodysplasia verruciformis

Preiser, W;Kapur, N;Snoeck, R.;Groves, RW;Brink, NS
(2000) Journal of Clinical Virology — Vol. 16, n° 1, p. 55-57 (2000)

Files

pdfdocument.pdf
  • Restricted Access
  • Adobe PDF
  • 168.81 KB

Details

Authors
  • Preiser, W
    Author
  • Kapur, N
    Author
  • Snoeck, R.
    Author
  • Groves, RW
    Author
  • Brink, NS
    Author
Abstract
This paper reports the failure of a patient suffering from Epidermodysplasia verruciformis, characterised by widespread infection of the skin with human papillomaviruses, to respond to topical and systemic treatment with the antiviral agent, Cidofovir, despite its previously demonstrated effectiveness against a range of different papillomavirus-associated conditions. (C) 2000 Published by Elsevier Science B.V. All rights reserved.
Affiliations

Citations

Preiser, W., Kapur, N., Snoeck, R., Groves, R., & Brink, N. (2000). No apparent effect of cidofovir in epidermodysplasia verruciformis. Journal of Clinical Virology, 16(1), 55-57. https://doi.org/10.1016/S1386-6532(99)00069-4 (Original work published 2000)